Overview 

On September 25, 2024, Medisetter hosted a landmark sponsored webinar titled New Update on the Treatment of Advanced NSCLC. The event was endorsed by CHEST (American College of Chest Physicians) and K Cancer Hospital, marking a significant milestone by virtue of securing official endorsement by, both, a local and international institution. This endorsement underscored the global relevance and high-quality content of the webinar, aimed at upskilling healthcare professionals in Vietnam in advanced lung cancer treatments.

Objectives 

The main objective was to upskill Oncologists and Pulmonologists in treatment of NSCLC, with a particular focus on the use of Vinorelbine oral therapy for treating NSCLC cases in complex patient profiles. The webinar intended to reinforce current global treatment guidelines and to increase awareness about the clinical efficacy and safety of oral chemotherapy in improving survival outcomes in NSCLC patients.

Speakers and Key Highlights

• Chairman: Dr. Do Anh Tu, Vice Director, K Hospital
• Speakers:
  • Prof. Dr. Silvestri GA from CHEST presented global NSCLC guidelines and clinical trials on Vinorelbine.
  • Dr. Vu Ha Thanh from K Hospital discussed persistent treatment gaps in Vietnam’s NSCLC care, showcasing a successful case study of Vinorelbine’s use.

Both speakers highlighted the significant role of Vinorelbine, particularly in improving treatment outcomes and managing side effects, reinforcing the importance of making this oral therapy more accessible within Vietnam.

Audience Engagement and Feedback The webinar attracted 184 attendees, mainly Oncologists, Pulmonologists and Respiratory specialists, achieving a high engagement rate:

• Show-up rate: 56% (above industry average)
• Average attendance duration: nearly 50 minutes, demonstrating strong interest and relevance.

Participants rated the content highly, with 100% giving a rating of 4 or above for both speaker presentations, and 96.7% rating the Q&A session ‘’ very effective’’ for knowledge dissemination.

Promotional Efforts Medisetter utilized a multi-channel approach to reach the target audience through:

• Medisetter mobile app
• Medisetter communities / contacts hosted on external Social media platforms (Facebook, Zalo)
• Email campaigns

Impact: The webinar set a new benchmark in Vietnam’s medical education landscape by securing the endorsement of the prestigious American College of Chest Physicians (CHEST). The high level of audience engagement demonstrated a clear interest in the latest advancements in NSCLC treatment and the practical applications of oral chemotherapy. The interactive sessions fostered in-depth discussions on Vinorelbine’s role in NSCLC management, especially for patients with complex comorbidities like renal and hepatic impairment.

Feedback from participants highlighted the value of aligning local treatment protocols with international guidelines, which could directly impact clinical decision-making and improve patient compliance. Attendees reported that the knowledge gained from case studies and treatment insights shared by esteemed speakers provided actionable takeaways that they could implement in their practice, potentially leading to improved patient outcomes. The event’s success underscores the growing demand for high-quality, evidence-based oncology education in Vietnam.